본문바로가기
Q
U
I
C
K

Global Innovative Partner of Vaccine and Biotech SK bioscience

From Prevention To Cure
mouse scroll icon SCROLL DOWN

Our Science & Technology

Conducting research into vaccines that will be the driving force in the life science business going forward.

The world's best vaccine factory with advanced vaccine technology.

Leading in expanding the global market through cooperation with global companies.

What’s New

  • SK bioscience News SK bioscience Expands Influenza Vac...

    750,000 doses of influenza vaccine to be supplied to Southeast Asia and Latin America in the first h...

    More
  • News Korea Begins Administration of...

    ? SK-Sanofi launches RSV preventive antibody injec...

    More
  • News SK bioscience Collaborates wit...

    -Collaborated with key global health authorities, ...

    More
  • News SK bioscience Secures Addition...

    SKYVaricella®, supplied to Latin America since 202...

    More
  • News SK bioscience Initiates Global...

    SK bioscience’s first mRNA vaccine candidate enter...

    More
  • News Korea Begins Administration of...

    ? SK-Sanofi launches RSV preventive antibody injec...

    More
  • News SK bioscience Collaborates wit...

    -Collaborated with key global health authorities, ...

    More
  • News SK bioscience Secures Addition...

    SKYVaricella®, supplied to Latin America since 202...

    More
  • News SK bioscience Initiates Global...

    SK bioscience’s first mRNA vaccine candidate enter...

    More

Investor Relations

0 PRESENT PRICE (WON)

0WON

0.00%

Our Products





PRODUCTS

SKYCellflu® Quadrivalent

SKYCellflu® Quadrivalent

[13494] 310, Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea
Company Registration Number 818-86-00991

Copyright(c) SK bioscience. All Right Reserved

접근성 마크
  GO